Herbal medicine and hepatocellular carcinoma: Applications and challenges

Evidence-based Complementary and Alternative Medicine

Volumn 2011, Issue , 2011, Pages

  Li, Yan ^a   Martin, Robert C G ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CURCUMIN; CYCLIN DEPENDENT KINASE 1; CYCLIN E; CYCLINE; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53; REACTIVE OXYGEN METABOLITE; RESVERATROL; SILIBININ; TANSHINONE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; CARCINOGENESIS; CHEMOEMBOLIZATION; HERBAL MEDICINE; LIVER CELL CARCINOMA; LIVER FIBROSIS; META ANALYSIS (TOPIC); METASTASIS INHIBITION; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW;

EID: 79953268388     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1093/ecam/neq044     Document Type: Review

References (96)

1. Weiss R., What is Herbal Medicine 1988 Beaconsfield, UK Beaconsfield Publishers
2. Liu G., Chinese Herbal Medicine (Clinical Essentials Series 2001 Beijing, China Hua Xia Publishing House
3. Liu G., Development of Formulas of Chinese Medicine 2002 Beijig, China Hua Xia Publishing House
4. Liu G., Fundamentals of Formulas of Chinese Medicine 2002 Beijing, China Hua Xia Publishing House
5. Yang L., Book of Changes And Traditional Chinese Medicine 2009 Beijing, China Beijing Science and Technology Press
6. Cheng H., Advanced Textbook on Traditional Chinese Medicine and Pharmacology 1995 Beijing, China New World Press
7. Fattovich G., Stroffolini T., Zagni I., Donato F., Hepatocellular carcinoma in cirrhosis: incidence and risk factors Gastroenterology 2004 127 5, supplement 1 S35 S50
8. Llovet J. M., Updated treatment approach to hepatocellular carcinoma Journal of Gastroenterology 2005 40 3 225 235 (Pubitemid 40613379)
9. Nagasue N., Kohno H., Chang Y.-C., Taniura H., Yamanoi A., Uchida M., Kimoto T., Takemoto Y., Nakamura T., Yukaya H., Liver resection for hepatocellular carcinoma: results of 229 consecutive patients during 11 years Annals of Surgery 1993 217 4 375 384 (Pubitemid 23115341)
10. Yamamoto J., Kosuge T., Takayama T., Shimada K., Yamasaki S., Ozaki H., Yamaguchi N., Makuuchi M., Recurrence of hepatocellular carcinoma after surgery British Journal of Surgery 1996 83 9 1219 1222 (Pubitemid 26290448)
11. Mathurin P., Raynard B., Dharancy S., Kirzin S., Fallik D., Pruvot F.-R., Roumilhac D., Canva V., Paris J.-C., Chaput J.-C., Naveau S., Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma Alimentary Pharmacology and Therapeutics 2003 17 10 1247 1261 (Pubitemid 36693726)
12. Ikeda K., Arase Y., Saitoh S., Kobayashi M., Suzuki Y., Suzuki F., Tsubota A., Chayama K., Murashima N., Kumada H., Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumora prospective randomized study of hepatitis C virusrelated liver cancer Hepatology 2000 32 2 228 232 (Pubitemid 30614654)
13. Lin S. M., Lin C. J., Hsu C. W., Tai D. I., Sheen I. S., Lin D. Y., Prospective randomized controlled study of interferon-alpha in preventing hepatocellular carcinoma recurrence after medical ablation therapy for primary tumors Cancer 2004 100 376 382
14. Takayama T., Sekine T., Makuuchi M., Yamasaki S., Kosuge T., Yamamoto J., Shimada K., Sakamoto M., Hirohashi S., Ohashi Y., Kakizoe T., Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial Lancet 2000 356 9232 802 807
15. Taieb J., Barbare J. C., Rougier P., Medical treatments for hepatocellular carcinoma (HCC): what's next? Annals of Oncology 2006 17 10 x308 x314
16. Llovet J. M., Bruix J., Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology 2003 37 2 429 442 (Pubitemid 36152543)
17. Lopez P. M., Villanueva A., Llovet J. M., Systematic review: evidence-based management of hepatocellular carcinomaan updated analysis of randomized controlled trials Alimentary Pharmacology Therapeutics 2006 23 1535 1547 (Pubitemid 43727460)
18. Ruan W. J., Lai M. D., Zhou J. G., Anticancer effects of Chinese herbal medicine, science or myth? Journal of Zhejiang University. Science. B. 2006 7 12 1006 1014
19. Treasure J., Herbal medicine and cancer: an introductory overview Seminars in Oncology Nursing 2005 21 3 177 183 (Pubitemid 41104990)
20. Luk J. M., Wang X., Liu P., Wong K.-F., Chan K.-L., Tong Y., Hui C.-K., Lau G. K., Fan S.-T., Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer: from laboratory discovery to clinical evaluation Liver International 2007 27 7 879 890 (Pubitemid 47261940)
21. Stickel F., Schuppan D., Herbal medicine in the treatment of liver diseases Digestive and Liver Disease 2007 39 4 293 304 (Pubitemid 46432239)
22. Cohen M. R., Herbal and complementary and alternative medicine therapies for liver disease: a focus on Chinese traditional medicine in hepatitis C virus Clinics in Liver Disease 2001 5 2 461 478 (Pubitemid 32475750)
23. Zhou B., Yao N. L., Generality of sera-pharmacologic experimental study on effect of Chinese herbal medicine on liver stellate cells Zhongguo Zhong Xi Yi Jie He Za Zhi 2004 24 4 376 379
24. Moher D., Cook D. J., Eastwood S., Olkin I., Rennie D., Stroup D. F., Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses Lancet 1999 354 1896 1900
25. Greenwald P., Milner J. A., Anderson D. E., McDonald S. S., Micronutrients in cancer chemoprevention Cancer and Metastasis Reviews 2002 21 3-4 217 230 (Pubitemid 36071911)
26. Milner J. A., Molecular targets for bioactive food components Journal of Nutrition 2004 134 9 2492S 2498S (Pubitemid 39201626)
27. Lpez-Lzaro M., Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent Molecular Nutrition and Food Research 2008 52 supplement 1 S103 S127
28. Chuang S. E., Kuo M. L., Hsu C. H., Chen C. R., Lin J. K., Lai G. M., Hsieh C. Y., Cheng A. L., Curcumin-containing diet inhibits diethylnitrosamine- induced murine hepatocarcinogenesis Carcinogenesis 2000 21 2 331 335 (Pubitemid 30098723)
29. Chuang S.-E., Cheng A.-L., Lin J.-K., Kuo M.-L., Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats Food and Chemical Toxicology 2000 38 11 991 995
30. Yoysungnoen P., Wirachwong P., Changtam C., Suksamrarn A., Patumraj S., Anti-cancer and anti-angiogenic effects of curcumin and tetrahydrocurcumin on implanted hepatocellular carcinoma in nude mice World Journal of Gastroenterology 2008 14 2003 2009 (Pubitemid 351795819)
31. Yoysungnoen P., Wirachwong P., Bhattarakosol P., Niimi H., Patumraj S., Effects of curcumin on tumor angiogenesis and biomarkers, COX-2 and VEGF, in hepatocellular carcinoma cell-implanted nude mice Clinical Hemorheology and Microcirculation 2006 34 1-2 109 115 (Pubitemid 43351018)
32. Yoysungnoen P., Wirachwong P., Bhattarakosol P., Niimi H., Patumraj S., Antiangiogenic activity of curcumin in hepatocellular carcinoma cells implanted nude mice Clinical Hemorheology and Microcirculation 2005 33 2 127 135 (Pubitemid 41254191)
33. Ohashi Y., Tsuchiya Y., Koizumi K., Sakurai H., Saiki I., Prevention of intrahepatic metastasis by curcumin in an orthotopic implantation model Oncology 2003 65 3 250 258 (Pubitemid 37505833)
34. Lin L.-I., Ke Y.-F., Ko Y.-C., Lin J.-K., Curcumin inhibits SK-Hep-1 hepatocellular carcinoma cell invasion in vitro and suppresses matrix metalloproteinase-9 secretion Oncology 1998 55 4 349 353 (Pubitemid 28279679)
35. Lv B. H., Zhang L., Zhu C. C., Liu J., [Inhibition of curcumin on histone deacetylase and expression promotion of P21 (WAF1/CIP1) in HepG2 cells] Zhongguo Zhong Yao Za Zhi 2007 32 2051 2055
36. Cao J., Liu Y., Jia L., Zhou H. M., Kong Y., Yang G., Curcumin induces apoptosis through mitochondrial hyperpolarization and mtDNA damage in human hepatoma G2 cells Free Radical Biology Medicine 2007 43 968 975 (Pubitemid 47223632)
37. Cao J., Jia L., Zhou H.-M., Liu Y., Zhong L.-F., Mitochondrial and nuclear DNA damage induced by curcumin in human hepatoma G2 cells Toxicological Sciences 2006 91 2 476 483 (Pubitemid 43827300)
38. Chan W.-H., Wu H.-J., Hsuuw Y.-D., Curcumin inhibits ROS formation and apoptosis in methylglyoxal-treated human hepatoma G2 cells Annals of the New York Academy of Sciences 2005 1042 372 378 (Pubitemid 40967659)
39. Ravindranath V., Chandrasekhara N., In vitro studies on the intestinal absorption of curcumin in rats Toxicology 1981 20 2-3 251 257 (Pubitemid 11117911)
40. Fang J.-Y., Hung C.-F., Chiu H.-C., Wang J.-J., Chan T.-F., Efficacy and irritancy of enhancers on the in-vitro and in-vivo percutaneous absorption of curcumin Journal of Pharmacy and Pharmacology 2003 55 5 593 601 (Pubitemid 36705570)
41. Lanon A., Hanet N., Jannin B., Delmas D., Heydel J.-M., Lizard G., Chagnon M.-C., Artur Y., Latruffe N., Resveratrol in human hepatoma HepG2 cells: metabolism and inducibility of detoxifying enzymes Drug Metabolism and Disposition 2007 35 5 699 703 (Pubitemid 46641555)
42. Bishayee A., Dhir N., Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis Chemico-Biological Interactions 2008 179 131 144
43. Stervbo U., Vang O., Bonnesen C., Time- and concentration-dependent effects of resveratrol in HL-60 and HepG2 cells Cell Proliferation 2006 39 6 479 493 (Pubitemid 44760200)
44. Notas G., Nifli A.-P., Kampa M., Vercauteren J., Kouroumalis E., Castanas E., Resveratrol exerts its antiproliferative effect on HepG2 hepatocellular carcinoma cells, by inducing cell cycle arrest, and NOS activation Biochimica et Biophysica Acta 2006 1760 11 1657 1666 (Pubitemid 44667277)
45. Yan F., Tian X. M., Ma X. D., Effects of resveratrol on growth inhibition and gap-junctional intercellular communication of HepG2 cells Nan Fang Yi Ke Da Xue Xue Bao 2006 26 7 963 966
46. Ma X. D., Yan F., Ma A. D., Wang H. J., Resveratrol induces HepG2 cell apoptosis by depolarizing mitochondrial membrane Nan fang yi ke da xue xue bao = Journal of Southern Medical University 2006 26 4 406 413
47. Yu H., Pan C., Zhao S., Wang Z., Zhang H., Wu W., Resveratrol inhibits tumor necrosis factor- -mediated matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells Biomedicine and Pharmacotherapy 2008 62 6 366 372 (Pubitemid 351899097)
48. Miura D., Miura Y., Yagasaki K., Hypolipidemic action of dietary resveratrol, a phytoalexin in grapes and red wine, in hepatoma-bearing rats Life Sciences 2003 73 11 1393 1400 (Pubitemid 36798126)
49. Miura D., Miura Y., Yagasaki K., Resveratrol inhibits hepatoma cell invasion by suppressing gene expression of hepatocyte growth factor via its reactive oxygen species-scavenging property Clinical Experimental Metastasis 2004 21 445 451
50. Walle T., Hsieh F., DeLegge M. H., Oatis J. E. Jr., Walle U. K., High absorption but very low bioavailability of oral resveratrol in humans Drug Metabolism and Disposition 2004 32 12 1377 1382 (Pubitemid 39564557)
51. Hebbar V., Shen G., Hu R., Kim B.-R., Chen C., Korytko P. J., Crowell J. A., Levine B. S., Kong A.-N. T., Toxicogenomics of resveratrol in rat liver Life Sciences 2005 76 20 2299 2314 (Pubitemid 40313418)
52. Jacobs B. P., Dennehy C., Ramirez G., Sapp J., Lawrence V. A., Milk thistle for the treatment of liver disease: a systematic review and meta-analysis American Journal of Medicine 2002 113 6 506 515 (Pubitemid 35335804)
53. Lieber C. S., Leo M. A., Cao Q., Ren C., DeCarli L. M., Silymarin retards the progression of alcohol-induced hepatic fibrosis in baboons Journal of Clinical Gastroenterology 2003 37 4 336 339 (Pubitemid 37158997)
54. Wellington K., Jarvis B., Silymarin: a review of its clinical properties in the management of hepaticdisorders BioDrugs 2001 15 465 489 (Pubitemid 32783707)
55. Singh R. P., Agarwal R., Prostate cancer chemoprevention by silibinin: bench to bedside Molecular Carcinogenesis 2006 45 6 436 442 (Pubitemid 43865852)
56. Singh R. P., Agarwal R., Mechanisms and preclinical efficacy of silibinin in preventing skin cancer European Journal of Cancer 2005 41 13 1969 1979 (Pubitemid 41557682)
57. Varghese L., Agarwal C., Tyagi A., Singh R. P., Agarwal R., Silibinin efficacy against human hepatocellular carcinoma Clinical Cancer Research 2005 11 23 8441 8448 (Pubitemid 41746959)
58. Lah J. J., Cui W., Hu K.-Q., Effects and mechanisms of silibinin on human hepatoma cell lines World Journal of Gastroenterology 2007 13 40 5299 5305 (Pubitemid 47559458)
59. Momeny M., Khorramizadeh M. R., Ghaffari S. H., Yousefi M., Yekaninejad M. S., Esmaeili R., Effects of silibinin on cell growth and invasive properties of a human hepatocellular carcinoma cell line, HepG-2, through inhibition of extracellular signal-regulated kinase 1/2 phosphorylation European Journal of Pharmacology 2008 591 13 20
60. Cao E.-H., Liu X.-Q., Wang J.-J., Xu N.-F., Effect of natural antioxidant Tanshinone II-A on DNA damage by lipid peroxidation in liver cells Free Radical Biology and Medicine 1996 20 6 801 806 (Pubitemid 26123854)
61. Zhao B.-L., Jiang W., Zhao Y., Hou J.-W., Xin W.-J., Scavenging effects of Salvia miltiorrhiza on free radicals and its protection for myocardial mitochondrial membranes from ischemia-reperfusion injury Biochemistry and Molecular Biology International 1996 38 6 1171 1182 (Pubitemid 26334731)
62. Wu W. L., Chang W. L., Chen C. F., Cytotoxic activities of tanshinones against human carcinoma cell lines American Journal of Chinese Medicine 1991 19 3-4 207 216
63. Ryu S. Y., Lee C. O., Choi S. U., In vitro cytotoxicity of tanshinones from Salvia miltiorrhiza Planta Medica 1997 63 4 339 342 (Pubitemid 27322428)
64. Yuan S. L., Wei Y. Q., Wang X. J., Xiao F., Li S. F., Zhang J., Growth inhibition and apoptosis induction of tanshinone II-A on human hepatocellular carcinoma cells World Journal of Gastroenterology 2004 10 2024 2028 (Pubitemid 39106951)
65. Zhong Z. H., Chen W. G., Liu Y. H., Li Q. X., Qiu Y., Inhibition of cell growth and induction of apoptosis in human hepatoma cell line HepG2 by tanshione IIA Zhong Nan Da Xue Xue Bao Yi Xue Ban 2007 32 99 103
66. Tang Z., Tang Y., Fu L., Growth inhibition and apoptosis induction in human hepatoma cells by tanshinone II A ournal of Huazhong University of Science and Technology Medical Science 2003 23 166 8, 172 (Pubitemid 41559748)
67. Wang X., Yuan S., Huang R., Song Y., [An observation of the effect of tanshinone on cancer cell proliferation by Brdu and PCNA labeling] Hua Xi Yi Ke Da Xue Xue Bao 1996 27 388 391 (Pubitemid 27028572)
68. Wang X., Yuan S., Wang C., A preliminary study of the anti-cancer effect of tanshinone on hepatic carcinoma and its mechanism of action in mice Zhonghua Zhong Liu Za Zhi 1996 18 6 412 414
69. Li Q., Wang Y., Feng N., Fan Z., Sun J., Nan Y., Novel polymeric nanoparticles containing tanshinone IIA for the treatment of hepatoma Journal of Drug Targeting 2008 16 10 725 732
70. Liu P., Mizoguchi Y., Morisawa S., Effects of magnesium lithospermate B on D-galactosamine induced rat liver injury Zhongguo Zhong Xi Yi Jie He Za Zhi 1993 13 6 352 326
71. Matsuzaki Y., Kurokawa N., Terai S., Matsumura Y., Kobayashi N., Okita K., Cell death induced by baicalein in human hepatocellular carcinoma cell lines Japanese Journal of Cancer Research 1996 87 2 170 177 (Pubitemid 26099492)
72. Tang P. M.-K., Chan J. Y.-W., Zhang D.-M., Au S. W.-N., Fong W.-P., Kong S.-K., Tsui S. K.-W., Waye M. M.-Y., Mak T. C.-W., Fung K.-P., Pheophorbide a, an active component in scutellaria barbata, reverses P-glycoprotein-mediated multidrug resistance on a human hepatoma cell line R-HepG2 Cancer Biology and Therapy 2007 6 4 504 509 (Pubitemid 47328323)
73. Juan M., Minhu C., Yun D., Liang Q., Enhancing the efficacy of photodynamic therapy by a Chinese herbal medicine for hepatocellular carcinoma Cancer Biology and Therapy 2006 5 9 1117 1119 (Pubitemid 44772224)
74. Tang P. M.-K., Chan J. Y.-W., Au S. W.-N., Kong S.-K., Tsui S. K.-W., Waye M. M.-Y., Mak T. C.-W., Fong W.-P., Fung K.-P., Pheophorbide a, an active compound isolated from Scutellaria barbata, possesses photodynamic activities by inducing apoptosis in human hepatocellular carcinoma Cancer Biology and Therapy 2006 5 9 1111 1116 (Pubitemid 44772223)
75. Yamashita Y., Moriyasu F., Ono S., Kimura T., Kajimura K., Someda H., Photodynamic therapy using pheophorbide-a and Q-switched Nd:YAG laser on implanted human hepatocellular carcinoma The Japanese Society of Gastroenterology 1991 26 623 627
76. Oka H., Yamamoto S., Kuroki T., Harihara S., Marumo T., Kim S. R., Monna T., Kobayashi K., Tango T., Prospective study of chemoprevention of hepatocellular carcinoma with Sho- saiko-to (TJ-9) Cancer 1995 76 5 743 749
77. Okita K., Li Q., Murakamio T., Takahashi M., Anti-growth effects with components of Sho-saiko-to (TJ-9) on cultured human hepatoma cells European Journal of Cancer Prevention) 1993 2 2 169 175
78. Yano H., Mizoguchi A., Fukuda K., Haramaki M., Ogasawara S., Momosaki S., Kojiro M., The herbal medicine sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0/G1 phase Cancer Research 1994 54 2 448 454 (Pubitemid 24053184)
79. Ha K.-T., Kim J.-K., Kang S.-K., Kim D.-W., Lee Y.-C., Kim H.-M., Kim C.-H., Inhibitory effect of Sihoga-Yonggol-Moryo-Tang on matrix metalloproteinase-2 and -9 activities and invasiveness potential of hepatocellular carcinoma Pharmacological Research 2004 50 3 279 285 (Pubitemid 38844482)
80. Watanabe S., Kitade Y., Masaki T., Nishioka M., Satoh K., Nishino H., Effects of lycopene and Sho-saiko-to on hepatocarcinogenesis in a rat model of spontaneous liver cancer Nutrition and Cancer 2001 39 1 96 101 (Pubitemid 32880954)
81. Kao S. T., Yang S. L., Hsieh C. C., Yang M. D., Wang T. F., Lin J. G., Immunomodulation of Bu-Zhong-Yi-Qi-Tang on in vitro granulocyte colony-stimulating-factor and tumor necrosis factor-alpha production by peripheral blood mononuclear cells Immunopharmacology and Immunotoxicology 2000 22 711 720
82. Lin J.-J., Jin C.-N., Zheng M.-L., Ouyang X.-N., Zeng J.-X., Dai X.-H., Clinical study on treatment of primary hepatocellular carcinoma by Shenqi mixture combined with microwave coagulation Chinese Journal of Integrative Medicine 2005 11 2 104 110 (Pubitemid 40980084)
83. Li X. R., Zhang D., Qi Y. F., Experimental study on xiaoliu pingyi mixture with medicated serum in inducing apoptosis of human hepatocellular carcinoma cell line H-7402 Zhongguo Zhong Xi Yi Jie He Za Zhi 2001 21 684 687
84. Chen T., Li D., Fu Y. L., Hu W., Screening of QHF formula for effective ingredients from Chinese herbs and its anti-hepatic cell cancer effect in combination with chemotherapy Chinese Medical Journal 2008 20 121 363 368 (Pubitemid 351479655)
85. Yin L. R., Chen Z. X., Zhang S. J., Sun B. G., Liu Y. D., Huang H. Z., Expression of phosphatase and tensin homolog deleted on chromosome ten in liver of athymic mice with hepatocellular carcinoma and the effect of Fuzheng Jiedu Decoction World Journal of Gastroenterology 2008 14 108 113
86. Lin L.-W., Sun Y., He Y.-M., Gao S.-D., Xue E.-S., Lin X.-D., Yu L.-Y., Lin X.-F., Yang Y.-H., Percutaneous intratumoral injection of traditional Chinese herbal compound medicine Star-99 in treatment of hepatocellular carcinoma of mice Hepatobiliary and Pancreatic Diseases International 2004 3 1 49 54 (Pubitemid 38256124)
87. Tsuchiya M., Kono H., Matsuda M., Fujii H., Rusyn I., Protective effect of Juzen-taiho-to on hepatocarcinogenesis is mediated through the inhibition of Kupffer cell-induced oxidative stress International Journal of Cancer 2008 123 11 2503 2511
88. Yamamoto S., Oka H., Kanno T., Mizoguchi Y., Kobayashi K., Controlled prospective trial to evaluate Syosakiko-to in preventing hepatocellular carcinoma in patients with cirrhosis of the liver Gan To Kagaku Ryoho 1989 16 4, part 2 1519 1524 (Pubitemid 19189483)
89. Meng M.-B., Cui Y.-L., Guan Y.-S., Ying Z., Zheng M.-H., Yuan C.-K., Zhang R.-M., Traditional Chinese medicine plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma Journal of Alternative and Complementary Medicine 2008 14 8 1027 1042
90. Shu X., McCulloch M., Xiao H., Broffman M., Gao J., Chinese herbal medicine and chemotherapy in the treatment of hepatocellular carcinoma: a meta-analysis of randomized controlled trials Integrative Cancer Therapies 2005 4 3 219 229 (Pubitemid 41153748)
91. Chen Z. X., Zhang S. J., Hu H. T., Sun B. G., Yin L. R., [Clinical study of method of strengthening body resistance and disintoxication disintoxication in patients with HCC of post-TACE] Zhongguo Zhong Yao Za Zhi 2007 32 1211 1213
92. Chao J. C.-J., Chiang S.-W., Wang C.-C., Tsai Y.-H., Wu M.-S., Hot water-extracted Lycium barbarum and Rehmannia glutinosa inhibit proliferation and induce apoptosis of hepatocellular carcinoma cells World Journal of Gastroenterology 2006 12 28 4478 4484 (Pubitemid 44256333)
93. Chang J.-S., Chiang L.-C., Hsu F.-F., Lin C.-C., Chemoprevention against hepatocellular carcinoma of Cornus officinalis in vitro American Journal of Chinese Medicine 2004 32 5 717 725 (Pubitemid 41435128)
94. Yamashiki M., Nishimura A., Nomoto M., Suzuki H., Kosaka Y., Herbal medicine 'Sho-saiko-to' induces tumour necrosis factor- and granulocyte colony-stimulating factor in vitro in peripheral blood mononuclear cells of patients with hepatocellular carcinoma Journal of Gastroenterology and Hepatology 1996 11 2 137 142 (Pubitemid 26122452)
95. Qian J., Zheng Z. S., Wu H. P., Li W. Y., Vossoughi D., Elsie O., Thomas V., Feng G. S., The application of Bletilla striata in the interventional therapy of hepatocellular carcinoma: a comparative study using ACI rats Zhonghua Gan Zang Bing Za Zhi 2005 13 2 143 144
96. Shiota G., Maeta Y., Mukoyama T., Yanagidani A., Udagawa A., Oyama K., Yashima K., Kishimoto Y., Nakai Y., Miura T., Ito H., Murawaki Y., Kawasaki H., Effects of Sho-saiko-to on hepatocarcinogenesis and 8-hydroxy-2′- deoxyguanosine formation Hepatology 2002 35 5 1125 1133 (Pubitemid 34454009)